Israeli PM Netanyahu says he was diagnosed with early-stage prostate cancer; recently had a successful operation without metastases; asked for a delayed publication amid the war with Iran, Journalist Stein reports

Israeli PM Netanyahu's diagnosis of early-stage prostate cancer, amid ongoing tensions with Iran, could raise concerns about political stability in the region. A successful operation suggests he may be able to maintain his leadership role, but uncertainty around his health could impact market sentiment, particularly in energy and gold, as geopolitical risks tend to influence safe-haven assets. Traders should watch for how this situation evolves and its potential implications for regional policies and broader market dynamics.